Publications for all Oxford Principal Investigators within the CAMS Oxford Institute are included here, please use the search functions for publications related to specific Principal Investigators.
Activity-based protein profiling reveals both canonical and novel ubiquitin pathway enzymes in Plasmodium
Smith C. et al, (2025), PLOS Pathogens, 21, e1013032 - e1013032
The ubiquitin E3 ligase Huwe1 facilitates viral and self RNA sensing by RIG-I-like receptors
Oosenbrug T. et al, (2025)
Altered Hormone and Bioactive Lipid Plasma Profile in Rodent Models of Polycystic Ovarian Syndrome Revealed by Targeted Mass Spectrometry
Scott HC. et al, (2025), Journal of Endocrinology and Metabolism, 15, 1 - 14
Transport and inhibition of the sphingosine-1-phosphate exporter SPNS2
Li HZ. et al, (2025), Nature Communications, 16
Structural Dynamics of the Ubiquitin Specific Protease USP30 in Complex with a Cyanopyrrolidine-Containing Covalent Inhibitor
O’Brien DP. et al, (2025), Journal of Proteome Research
The developmental environment mediates adult seminal proteome allocation in maleDrosophila melanogaster
von Hellfeld R. et al, (2025)
USP4 Auto-Deubiquitylation Promotes Homologous Recombination.
Wijnhoven P. et al, (2025), Molecular cell
Protocol to profile spatially resolved NLRP3 inflammasome complexes using APEX2-based proximity labeling
Liang Z. et al, (2024), STAR Protocols, 5, 103417 - 103417
Ubiquitylation of nucleic acids by DELTEX ubiquitin E3 ligase DTX3L
Zhu K. et al, (2024), EMBO Reports
USP24 is an ISG15 cross-reactive deubiquitinase that mediates IFN-I production by de-ISGylating the RNA helicase MOV10
Mukhopadhyay R. et al, (2024)
Cyclin F–EXO1 axis controls cell cycle–dependent execution of double-strand break repair
Yang H. et al, (2024), Science Advances, 10
Cyclin A/B RxL Macrocyclic Inhibitors to Treat Cancers with High E2F Activity.
Singh S. et al, (2024)